France· FR:69817200
DORZOLAMIDE EG 20 mg/mL, collyre en solution
A dorzolamide product containing chlorhydrate de dorzolamide, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Dorzolamide is registered in 19 of 19 countries.
Countries holding a registration under ATC S01EC03 (dorzolamide), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Dorzolamide · ATC S01EC03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE DORZOLAMIDE
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- S01EC03
- ATC class
- Dorzolamide
- Defined daily dose
- 0.3 ml, AT
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009498775391 flacon(s) polyéthylène de 5 mlEUR 4.41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for dorzolamide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dorzolamide · interactions on record
4 records
- 4 severe
Most severe, free to view
- Acetylsalicylic acidB01AC06severe
- Salicylic acidD01AE12severe
- Acetylsalicylic acidN02BA01severe
- Salicylic acidS01BC08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dorzolamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDORZOLAMID OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- United StatesDorzolamide HClBausch & Lomb Incorporated
- FinlandAikumSanoSwiss UAB
- BelgiumCosopt 20 mg/ml - 5 mg/mlPI Pharma
- NetherlandsDorzolamide Aurobindo 20 mg/ml oogdruppels, oplossingAurobindo Pharma B.V.
- PolandDorzolamid BIJONBIJON medica, UAB
- SwedenDimaz 20 mg/ml Ögondroppar, lösningZaklady Farmaceutyczne Polpharma SA
- NorwayDorzolamid al compAliud Pharma
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Dorlazept, Dorzo-Vision
- Belgium · Trusopt, Trusopt 2 % Unit Dose
- Bulgaria · Дорзамед
- Cyprus · Dorolad, Dorzon
- Czechia · Dorzolamid Olikla, Dorzolamide Farmaprojects
- Germany · Dimaz, Dorlazept
- Denmark · Delazo, Dorzolamid Hexal
- Estonia · Dorzolamide Elvim, Trusopt
- Spain · Arzolan, Dimaz
- Finland · Itoco, Odyral
- United Kingdom (Northern Ireland) · Dimaz, Dorzolamide
- Greece · Delazo, Dorolad
- Croatia · Dorvis, Dorzol
- Hungary · Dorzolep, Trusopt
- Ireland · Itoco, Trusopt
- Iceland · Dorzolamide Alvogen
- Italy · Dorzoclar, Dorzolamide Aurobindo
- Lithuania · Dorzolamide Actavis, Dorzolamide Elvim
- Luxembourg · Dorzo-Vision, Trusopt 2 % Unit Dose
- Latvia · Dorzolamide Actavis, Dorzolamide Elvim
- Netherlands · Dorzolamide Hydrochloride Aurobindo, Dorzolamide Viatris
- Norway · Dimaz, Trusopt
- Poland · Dorzostill, Nodofree
- Portugal · Dimaz, Dorcil
- Romania · Dorzolamidă Arena, Dorzopt
- Sweden · Dimaz, Dorzolamid Hexal
- Slovakia · Dorzolamid Olikla, Dozotens
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad651fe6-cde1-4e6f-8d0d-b6f9d85b64f1 GET /v1/drugs/ad651fe6-cde1-4e6f-8d0d-b6f9d85b64f1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69817200",
"date_amm": "2011-01-31",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE DORZOLAMIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about dorzolamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.